Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02973932
Other study ID # F.1331477
Secondary ID
Status Not yet recruiting
Phase N/A
First received November 7, 2016
Last updated November 25, 2016
Start date November 2016

Study information

Verified date November 2016
Source University Hospital Tuebingen
Contact Annette Conzelmann, PhD
Phone 004970712987513
Email annette.conzelmann@med.uni-tuebingen.de
Is FDA regulated No
Health authority Germany: Ethics Commission
Study type Interventional

Clinical Trial Summary

Internet-based psychotherapy for children and adolescents with obsessive-compulsive symptoms and an age of 7 to 17 years. Sessions are verified with teleconferencing with an psychotherapist, children and their parents. The psychotherapy is supported by an App and a wristband to obtain psychophysiological data.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 20
Est. completion date
Est. primary completion date November 2017
Accepts healthy volunteers No
Gender Both
Age group 7 Years to 17 Years
Eligibility Inclusion Criteria:

- Children and adolescents (ages 7-17) with a primary DSM-5 obsessive-compulsive disorder and at least 1 primary caretaker

- German-speaking (child & caretakers)

- Family home equipped with broadband connection and appropriate computer, monitor, HD webcam, and speaker and smart phone

Exclusion Criteria:

- IQ below 70

- A psychiatric comorbidity that makes participation clinically inappropriate (for example, primary anorexia nervosa), depression with suicidality that requires acute treatment, and psychosis

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Cognitive-bahavioral psychotherapy


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University Hospital Tuebingen

Outcome

Type Measure Description Time frame Safety issue
Primary The Schedule for Affective Disorders and Schizophrenia for School-Age Children Present and Lifetime Version (K-SADS-PL) beginning of the study and end therapy (about 16 weeks) No
Primary The Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS) beginning of the study and end therapy (about 16 weeks) No
Primary Children's Global Assessment Scale (CGAS) beginning of the study and end therapy (about 16 weeks) No
Primary Child Behavior Checklist (CBCL) beginning of the study and end therapy (about 16 weeks) No
Primary Questionnaire for Measuring Health-Related Quality of Life in Children and Adolescents (KINDL) beginning of the study and end therapy (about 16 weeks) No
Primary Impairment by OCD symptoms assessed by App Every day throughout the therapy process (14 weeks) No
Primary Extend of avoidance behavior assessed by App Every day throughout the therapy process (14 weeks) No
Primary Daily mood assessed by App Every day throughout the therapy process (14 weeks) No
Primary How the day was assessed by App Every day throughout the therapy process (14 weeks) No
Primary How strong OCD is assessed by App Every week throughout the therapy process (14 weeks) No
Primary How Every week throughout the therapy processgood e progress was with specific treatment goals assessed by App Every week throughout the therapy process (14 weeks) No
Primary Anxiety ratings during exposures assessed by App Every week three days beginning with session 4 up to 14 No
Primary Heart rate variability assessed with wristband Every day throughout the therapy (14 weeks) No
Primary Skin conductance level assessed with wristband Every day throughout the therapy (14 weeks) No
Primary Body temperature assessed with wristband Every day throughout the therapy (14 weeks) No
Primary Body movements assessed with wristband Every day throughout the therapy (14 weeks) No
See also
  Status Clinical Trial Phase
Completed NCT05037344 - iCBT for Children and Adolescents With Obsessive-compulsive Disorder II N/A